Inocras Company
Inocras provides AI-driven genomic analysis focused on cancer and rare diseases. The company offers whole genome sequencing products, including CancerVision, RareVision, and MRDVision, alongside research services for pharmaceutical and biotechnology organizations through its CAP/CLIA-certified laboratory. Inocras employs a proprietary bioinformatics pipeline to process genomic data, supporting insights for both clinical and research applications. The company integrates sequencing and computational analysis to enable precision health approaches based on individual genomic information.
Founded Date:
2020-01-09 00:00:00
Industry:
BioPharma AI
Headquarters:
San Diego,California,United States,North America
Technology:
AI-driven Drug Target Identification
Funding Status:
private